This page in English
Laddar profil information

Publikationer

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
Saeed K, Ojamies P, Pellinen T, Eldfors S, Turkki R, Lundin J, et al
International journal of cancer 2019;144(6):1356-1366

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours
Linder N, Taylor Jc, Colling R, Pell R, Alveyn E, Joseph J, et al
Journal of clinical pathology 2019;72(2):157-164

Deep learning based tissue analysis predicts outcome in colorectal cancer
Bychkov D, Linder N, Turkki R, Nordling S, Kovanen Pe, Verrill C, et al
Scientific reports 2018;8(1):3395-

The prognostic significance of tall cells in papillary thyroid carcinoma: A case-control study
Stenman S, Siironen P, Mustonen H, Lundin J, Haglund C, Arola J
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2018;40(7):1010428318787720-

A roadmap for the implementation of mHealth innovations for image-based diagnostic support in clinical and public-health settings: a focus on front-line health workers and health-system organizations
Wallis L, Hasselberg M, Barkman C, Bogoch I, Broomhead S, Dumont G, et al
Global health action 2017;10(sup3):1340254-

Deep learning for image-based diagnostic support: initial development of a system for acute burns
Boissin C, Fransen J, Laflamme L, Allorto N, Wallis L, Huss F, et al
EUROPEAN JOURNAL OF PUBLIC HEALTH 2017;:436-436

Medical mobile technologies - what is needed for a sustainable and scalable implementation on a global scale?
Lundin J, Dumont G
Global health action 2017;10(sup3):1344046-

Mobile phone and handheld microscopes for public health applications
Bogoch Ii, Lundin J, Lo Nc, Andrews Jr
LANCET PUBLIC HEALTH 2017;2(8):E355-E355

Mobile phone and handheld microscopes for public health applications
Bogoch Ii, Lundin J, Lo Nc, Andrews Jr
The Lancet. Public health 2017;2(8):e355-

Point-of-care mobile digital microscopy and deep learning for the detection of soil-transmitted helminths and Schistosoma haematobium
Holmström O, Linder N, Ngasala B, Mårtensson A, Linder E, Lundin M, et al
Global health action 2017;10(sup3):1337325-

Precision systems medicine in urological Tumors - Molecular profiling and functional testing
Saeed K, Ojamies P, Pellinen T, Rahkama V, Eldfors S, Paavolainen L, et al
ANNALS OF ONCOLOGY 2017;

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki-teeri P, Hemmes A, et al
Scientific reports 2017;7(1):15580-

Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples
Turkki R, Linder N, Kovanen Pe, Pellinen T, Lundin J
Journal of pathology informatics 2016;7():38-

A Smartphone App and Cloud-Based Consultation System for Burn Injury Emergency Care
Wallis La, Fleming J, Hasselberg M, Laflamme L, Lundin J
PloS one 2016;11(2):e0147253-

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus
Taipale K, Liikanen I, Juhila J, Turkki R, Tahtinen S, Kankainen M, et al
MOLECULAR THERAPY 2016;24(1):175-83

Immune cell profiling in CML bone marrow by multiplex IHC
Bruck O, Blom S, Turkki R, Kovanen P, Ribeiro A, Linder N, et al
ANNALS OF ONCOLOGY 2016;

Immune Cell Profiling in CML Bone Marrow By Multiplex Immunohistochemistry
Oscar B, Blom S, Turkki R, Kovanen Pe, Ribeiro A, Linder N, et al
BLOOD 2016;128(22)

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
Lahdensuo K, Erickson A, Saarinen I, Seikkula H, Lundin J, Lundin M, et al
MODERN PATHOLOGY 2016;29(12):1565-1574

Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Ranki T, Pesonen S, Hemminki A, Partanen K, Kairemo K, Alanko T, et al
Journal for immunotherapy of cancer 2016;4():17-

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions
Saeed K, Östling P, Björkman M, Mirtti T, Alanen K, Vesterinen T, et al
International journal of cancer 2015;136(11):2535-45

An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors.
Pesonen Sa, Ranki T, Jager E, Karbach J, Wahle C, Joensuu Tk, et al
JOURNAL OF CLINICAL ONCOLOGY 2015;33(15)

Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis
Turkki R, Linder N, Holopainen T, Wang Y, Grote A, Lundin M, et al
Journal of clinical pathology 2015;68(8):614-21

Benefit of adjuvant interferon alfa-2b (IFN-alpha) therapy in melanoma patients with high serum MMP-8 levels
Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, et al
CANCER IMMUNOLOGY IMMUNOTHERAPY 2015;64(2):173-80

Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers
Vassilev B, Sihto H, Li Sq, Holtta-vuori M, Ilola J, Lundin J, et al
AMERICAN JOURNAL OF PATHOLOGY 2015;185(4):987-1000

Exploring viewing behavior data from whole slide images to predict correctness of students' answers during practical exams in oral pathology
Walkowski S, Lundin M, Szymas J, Lundin J
Journal of pathology informatics 2015;6():28-

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy
Hemminki O, Parviainen S, Juhila J, Turkki R, Linder N, Lundin J, et al
Oncotarget 2015;6(6):4467-81

Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner
Holmström O, Linder N, Lundin M, Moilanen H, Suutala A, Turkki R, et al
PloS one 2015;10(12):e0144688-

Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8(+) T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
Vassilev L, Ranki T, Joensuu T, Jager E, Karbach J, Wahle C, et al
ONCOIMMUNOLOGY 2015;4(7):e1017702-

Systems pathology for characterization of cancer model systems in a multicenter IMI-PREDECT project
Blom S, Wang Yh, Metsalu T, Vesterinen T, Pellinen T, Grote A, et al
CANCER RESEARCH 2015;

T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses
Taipale K, Liikanen I, Juhila J, Karioja-kallio A, Oksanen M, Turkki R, et al
MOLECULAR THERAPY 2015;23(5):964-973

A malaria diagnostic tool based on computer vision screening and visualization of Plasmodium falciparum candidate areas in digitized blood smears
Linder N, Turkki R, Walliander M, Mårtensson A, Diwan V, Rahtu E, et al
PloS one 2014;9(8):e104855-

Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer
Grote A, Abbas M, Linder N, Kreipe Hh, Lundin J, Feuerhake F
DIAGNOSTIC PATHOLOGY 2014;:S11-

Exploring Viewing Behavior Data from Whole Slide Images to Predict Correctness of Students' Answers during Practical Exams in Oral Pathology
Walkowski S, Lundin M, Szymas J, Lundin J
ANALYTICAL CELLULAR PATHOLOGY 2014;

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8(+) T-cell response, prominent infiltration of CD8(+) lymphocytes and Th1 type polarization
Ranki T, Joensuu T, Jager E, Karbach J, Wahle C, Kairemo K, et al
ONCOIMMUNOLOGY 2014;3(10):e958937-

Students' performance during practical examination on whole slide images using view path tracking
Walkowski S, Lundin M, Szymas J, Lundin J
DIAGNOSTIC PATHOLOGY 2014;:208-

Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
Imi Predect Consortium, Hickman Ja, Graeser R, De Hoogt R, Vidic S, Brito C, et al
BIOTECHNOLOGY JOURNAL 2014;9(9):1115-28

On-chip imaging of Schistosoma haematobium eggs in urine for diagnosis by computer vision
Linder E, Grote A, Varjo S, Linder N, Lebbad M, Lundin M, et al
PLoS neglected tropical diseases 2013;7(12):e2547-

Students' performance during practical examination on whole slide imaging using viewpath tracking
Szymas J, Walkowski S, Lundin M, Lundin J
VIRCHOWS ARCHIV 2013;463(2):109-110

The Case Database of the European Congresses of Pathology: Current status and planned features
Lundin M, Szymas J, Lundin J
VIRCHOWS ARCHIV 2013;463(2):107-108

A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation
Sampo M, Tarkkanen M, Tukiainen E, Popov P, Gustafson P, Lundin M, et al
BRITISH JOURNAL OF CANCER 2012;106(6):1076-82

Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma
Linder N, Butzow R, Lassus H, Lundin M, Lundin J
GYNECOLOGIC ONCOLOGY 2012;124(2):311-8

Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium
Konsti J, Lundin M, Linder N, Haglund C, Blomqvist C, Nevanlinna H, et al
DIAGNOSTIC PATHOLOGY 2012;:29-

Identification of tumor epithelium and stroma in tissue microarrays using texture analysis
Linder N, Konsti J, Turkki R, Rahtu E, Lundin M, Nordling S, et al
DIAGNOSTIC PATHOLOGY 2012;:22-

An Extensive Tumor Array Analysis Supports Tumor Suppressive Role for Nucleophosmin in Breast Cancer
Karhemo Pr, Rivinoja A, Lundin J, Hyvonen M, Chernenko A, Lammi J, et al
AMERICAN JOURNAL OF PATHOLOGY 2011;179(2):1004-14

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
Sihto H, Lundin J, Lundin M, Lehtimaki T, Ristimaki A, Holli K, et al
BREAST CANCER RESEARCH 2011;13(5):R87-

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
Konsti J, Lundin M, Joensuu H, Lehtimäki T, Sihto H, Holli K, et al
BMC clinical pathology 2011;11():3-

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, et al
EMBO JOURNAL 2011;30(19):3962-76

Expression and prognostic value of transcription factor PROX1 in colorectal cancer
Skog M, Bono P, Lundin M, Lundin J, Louhimo J, Linder N, et al
BRITISH JOURNAL OF CANCER 2011;105(9):1346-51

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
Bockelman C, Hagstrom J, Makinen Lk, Keski-santti H, Hayry V, Lundin J, et al
BRITISH JOURNAL OF CANCER 2011;104(12):1890-5

Long-term prognosis of breast cancer detected by mammography screening or other methods
Lehtimaki T, Lundin M, Linder N, Sihto H, Holli K, Turpeenniemi-hujanen T, et al
BREAST CANCER RESEARCH 2011;13(6):R134-

Pharmacokinetics of alkylresorcinol metabolites in human urine
Soderholm Pp, Lundin Je, Koskela Ah, Tikkanen Mj, Adlercreutz Hc
BRITISH JOURNAL OF NUTRITION 2011;106(7):1040-4

PLA2G7 associates with aggressive prostate cancer in vivo and regulates prostate cancer cell migration and adhesion in vitro
Vainio P, Hilvo M, Vesterinen T, Gupta S, Harma V, Nees M, et al
CANCER RESEARCH 2011;

WebMicroscope as a computer-based system for the practical examination of dental students in oral pathology
Szymas J, Lundin M, Lundin J
VIRCHOWS ARCHIV 2011;:S40-S40

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha 2a as first line treatment in metastatic melanoma
Vihinen Pp, Hernberg M, Vuoristo Ms, Tyynela K, Laukka M, Lundin J, et al
MELANOMA RESEARCH 2010;20(4):318-25

Automated vision quantitative assessment of Ki-67 proliferation index in a nationwide series of patients with breast cancer
Konsti J, Lundin M, Joensuu H, Lundin J
VIRCHOWS ARCHIV 2010;457(2):147-147

A web-based examination system for students using WebMicroscopy for learning oral pathology
Szymas J, Lundin M, Lundin J
VIRCHOWS ARCHIV 2010;457(2):148-148

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
Häyry V, Mäkinen Lk, Atula T, Sariola H, Mäkitie A, Leivo I, et al
British journal of cancer 2010;102(5):892-7

Can Head Position after Anesthesia Cause Occlusion of the Tympanostomy Tube?
Kinnari Tj, Aarnisalo Aa, Rihkanen H, Lundin J, Jero J
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 2010;39(1):1-4

CIP2A IS A MARKER OF REDUCED SURVIVAL IN TONGUE CANCER PATIENTS
Bockelman C, Hagstrom J, Makinen Lk, Lundin J, Atula T, Westermarck J, et al
TUMOR BIOLOGY 2010;:S97-S97

Five years of experiences with WebMicroscope for teaching basic and oral pathology in a practical course
Szymas J, Lundin M
VIRCHOWS ARCHIV 2010;457(2):147-148

Mammary-derived growth inhibitor (MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and invasion
Nevo J, Mai A, Tuomi S, Pellinen T, Pentikainen Ot, Heikkila P, et al
ONCOGENE 2010;29(49):6452-63

ONCOPOOL, a comparison with SEER
Lundin J, Holli K, Lundin M, Hornmark-stenstam B, Ball G, Blamey R
EJC SUPPLEMENTS 2010;8(3):101-101

The Proportion of Free PSA and Upgrading of Biopsy Gleason Score after Radical Prostatectomy
Visapaa H, Hotakainen K, Lundin J, Ala-opas M, Stenman Uh
UROLOGIA INTERNATIONALIS 2010;84(4):378-81

A European network for virtual microscopy-design, implementation and evaluation of performance
Lundin M, Szymas J, Linder E, Beck H, De Wilde P, Van Krieken H, et al
VIRCHOWS ARCHIV 2009;454(4):421-9

Arrangement of large scale web slide seminars. Experiences from the ECP 2007 and ECP 2009
Lundin M, Konsti J, Lundin J
VIRCHOWS ARCHIV 2009;:35-35

Plasma pharmacokinetics of alkylresorcinol metabolites: new candidate biomarkers for whole-grain rye and wheat intake
Söderholm Pp, Koskela Ah, Lundin Je, Tikkanen Mj, Adlercreutz Hc
The American journal of clinical nutrition 2009;90(5):1167-71

Texture classifiers for breast cancer outcome prediction
Konsti J, Ahonen T, Lundin M, Joensuu H, Pietikainen M, Lundin J
VIRCHOWS ARCHIV 2009;:34-34

Xanthine oxidoreductase - Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells
Linder N, Martelin E, Lundin M, Louhimo J, Nordling S, Haglund C, et al
EUROPEAN JOURNAL OF CANCER 2009;45(4):648-55

A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals
Konsti J, Lundin J, Jumppanen M, Lundin M, Viitanen A, Isola J
JOURNAL OF CLINICAL PATHOLOGY 2008;61(3):278-82

CIP2A (Cancerous Inhibitor of Protein Phosphatase 2A) promotes gastric carcinogenesis
Khanna A, Bockelman C, Hemmes A, Junttila M, Wiksten Jp, Lundin M, et al
EJC SUPPLEMENTS 2008;6(9):48-48

Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer
Wiksten Jp, Lundin J, Nordling S, Kokkola A, Haglund C
ANTICANCER RESEARCH 2008;28(4C):2279-87

Molecular subtypes of breast cancers detected in mammography screening and outside of screening
Sihto H, Lundin J, Lehtimäki T, Sarlomo-rikala M, Bützow R, Holli K, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(13):4103-10

Web-Based Virtual Microscopy for Parasitology: A Novel Tool for Education and Quality Assurance
Linder E, Lundin M, Thors C, Lebbad M, Winiecka-krusnell J, Helin H, et al
PLOS NEGLECTED TROPICAL DISEASES 2008;2(10):e315-

Association of Wwox with ErbB4 in breast cancer
Aqeilian Ri, Donati V, Gaudio E, Nicoloso Ms, Sundvall M, Korhonen A, et al
CANCER RESEARCH 2007;67(19):9330-6

Breast cancer detection in mammography screening has independent influence on survival when cancer size and biological subtype are accounted for
Sihto H, Puputti M, Heikkila R, Lehtimaki T, Holli K, Kataja V, et al
EJC SUPPLEMENTS 2007;5(4):97-97

Ki-67, p53, ER receptors, Ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer
Railo M, Lundin J, Haglund C, Von Smitten K, Nordling S
TUMOR BIOLOGY 2007;28(1):45-51

Tenascin-C expression and its prognostic significance in colorectal cancer
Lundin M, Nordling S, Lundin J, Haglund C
ONCOLOGY 2007;72(5-6):403-9

The Nottingham Prognostic Index - from relative to absolute risk prediction
Lundin J
EUROPEAN JOURNAL OF CANCER 2007;43(10):1498-500

A web-based method for external validation of survival estimates based on a nationwide series of patients with breast cancer
Johan L, Lehtimaki T, Lundin M, Isola J, Joensuu H
TUMOR BIOLOGY 2006;:30-30

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer
Linder N, Haglund C, Lundin M, Nordling S, Ristimaki A, Kokkola A, et al
JOURNAL OF CLINICAL PATHOLOGY 2006;59(9):965-71

Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer
Juuti A, Lundin J, Nordling S, Louhimo J, Haglund C
ONCOLOGY 2006;71(1-2):61-8

Generalisability of survival estimates for patients with breast cancer - A comparison across two population-based series
Lundin J, Lehtimaki T, Lundin M, Holli K, Elomaa L, Turpeenniemi-hujanen T, et al
EUROPEAN JOURNAL OF CANCER 2006;42(18):3228-35

Virtual microscopy in prostate histopathology: Simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry
Helin Ho, Lundin Me, Laakso M, Lundin J, Helin Hj, Isola J
JOURNAL OF UROLOGY 2006;175(2):495-9

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer
Sivula A, Talvensaari-mattila A, Lundin J, Joensuu H, Haglund C, Ristimaki A, et al
BREAST CANCER RESEARCH AND TREATMENT 2005;89(3):215-20

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
Junttila Tt, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P, et al
CANCER RESEARCH 2005;65(4):1384-93

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR
Mrena J, Wiksten Jp, Thiel A, Kokkola A, Pohjola L, Lundin J, et al
CLINICAL CANCER RESEARCH 2005;11(20):7362-8

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma
Heinonen M, Bono P, Narko K, Chang Sh, Lundin J, Joensuu H, et al
CANCER RESEARCH 2005;65(6):2157-61

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early stage gastric cancer
Linder N, Haglund C, Nordling S, Lundin M, Raivio K, Lundin J
EJC SUPPLEMENTS 2005;3(2):216-216

Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer
Linder N, Lundin J, Isola J, Lundin M, Raivio Ko, Joensuu H
CLINICAL CANCER RESEARCH 2005;11(12):4372-81

Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer
Lundin M, Nordling S, Lundin J, Isola J, Wilksten Jp, Haglund C
ONCOLOGY 2005;68(4-6):306-13

High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer
Wiksten Jp, Lundin J, Nordling S, Kokkola A, Stenman Uh, Haglund C
HISTOPATHOLOGY 2005;46(4):380-8

Syndecan-1 expression - A novel prognostic marker in pancreatic cancer
Juuti A, Nordling S, Lundin J, Louhimo J, Haglund C
ONCOLOGY 2005;68(2-3):97-106

Web-based virtual microscopy in teaching and standardizing Gleason grading
Helin H, Lundin M, Lundin J, Martikainen P, Tammela T, Helin H, et al
HUMAN PATHOLOGY 2005;36(4):381-6

A digital atlas of breast histopathology: an application of web based virtual microscopy
Lundin M, Lundin J, Helin H, Isola J
JOURNAL OF CLINICAL PATHOLOGY 2004;57(12):1288-91

High LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in breast cancer.
Bono P, Wasenius Vm, Lundin J, Jackson Dg, Joensuu H
JOURNAL OF CLINICAL ONCOLOGY 2004;22(14):839S-839S

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer
Bono P, Wasenius Vm, Heikkila P, Lundin J, Jackson Dg, Joensuu H
CLINICAL CANCER RESEARCH 2004;10(21):7144-9

Prognostic value of syndecan-1 expression in breast cancer
Leivonen M, Lundin J, Nordling S, Von Boguslawski K, Haglund C
ONCOLOGY 2004;67(1):11-8

Risk for distant recurrence of breast cancer detected by mammography screening or other methods
Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-hujanen T, Kataja V, et al
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2004;292(9):1064-73

Spontaneous regression of cancerous tumors detected by mammography screening - In reply
Joensuu H, Lundin J
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2004;292(21):2580-2580

Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation
Juuti A, Nordling S, Louhimo J, Lundin J, Haglund C
JOURNAL OF CLINICAL PATHOLOGY 2004;57(11):1151-5

Validation of a Web-based prognostic system for breast cancer
Lundin J, Lundin M, Isola J, Joensuu H
Studies in health technology and informatics 2004;107(Pt 1):237-40

Virtual microscopy
Lundin M, Lundin J, Isola J
JOURNAL OF CLINICAL PATHOLOGY 2004;57(12):1250-1

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: A nationwide population-based study
Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, et al
CLINICAL CANCER RESEARCH 2003;9(3):923-30

A web-based system for individualised survival estimation in breast cancer
Lundin J, Lundin M, Isola J, Joensuu H
BMJ-BRITISH MEDICAL JOURNAL 2003;326(7379):29-

Distinct subtypes of serous ovarian carcinoma identified by p53 determination
Lassus H, Leminen A, Lundin J, Lehtovirta P, Butzow R
GYNECOLOGIC ONCOLOGY 2003;91(3):504-12

Evaluation of a web-based system for survival estimation in breast cancer
Lundin J, Lundin M, Isola J, Joensuu H
Studies in health technology and informatics 2003;95():788-93

Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer
Juuti A, Nordling S, Louhimo J, Lundin J, Von Boguslawski K, Haglund C
ONCOLOGY 2003;65(4):371-7

Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas
Zhang F, Lundin M, Ristimaki A, Heikkila P, Lundin J, Isola J, et al
CANCER RESEARCH 2003;63(16):5005-10

Tenascin-C expression correlates with prognosis in gastric cancer
Wiksten Jp, Lundin J, Nordling S, Lundin M, Kokkola A, Von Boguslawski K, et al
ONCOLOGY 2003;64(3):245-50

Are some patients cured after local therapy alone? Clues based on natural history data from Turku Finland.
Esserman Lj, Miller Jr, Tripathy D, Joensuu H, Lundin M, Lundin J, et al
BREAST CANCER RESEARCH AND TREATMENT 2002;:S48-S48

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, et al
CANCER RESEARCH 2002;62(3):632-5

The prognostic value of p27 in gastric cancer
Wiksten Jp, Lundin J, Nordling S, Kokkola A, Von Boguslawski K, Haglund C
ONCOLOGY 2002;63(2):180-4

Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array
Rummukainen Jk, Salminen T, Lundin J, Kytola S, Joensuu H, Isola Jj
MODERN PATHOLOGY 2001;14(10):1030-5

Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples
Rummukainen Jk, Salminen T, Lundin J, Joensuu H, Isola Jj
LABORATORY INVESTIGATION 2001;81(11):1545-51

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer
Wiksten Jp, Lundin J, Nordling S, Lundin M, Kokkola A, Von Bocuslawski K, et al
INTERNATIONAL JOURNAL OF CANCER 2001;95(1):1-6

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study
Lundin J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkanen L, et al
JOURNAL OF CLINICAL ONCOLOGY 2001;19(1):28-36

p27 expression correlates with short-term, but not with long-term prognosis in breast cancer
Leivonen M, Nordling S, Lundin J, Von Boguslawski K, Haglund C
BREAST CANCER RESEARCH AND TREATMENT 2001;67(1):15-22

Prognostic model development and individualized survival prediction in malignant uveal melanoma.
Lundin J, Makitie T, Lundin M, Summanen P, Kivela T
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 2001;42(4):S109-S109

Redo bypass surgery to the infrapopliteal arteries for critical leg ischaemia
Biancari F, Railo M, Lundin J, Alback A, Kantonen I, Lehtola A, et al
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY 2001;21(2):137-42

Serum tumour markers CA 15-3, TPA, TPS, hCG beta and TATI in the monitoring of chemotherapy response in metastatic breast cancer
Sjostrom J, Alfthan H, Joensuu H, Stenman Uh, Lundin J, Blomqvist C
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 2001;61(6):431-41

STn and prognosis in breast cancer
Leivonen M, Nordling S, Lundin J, Von Boguslawski K, Haglund C
ONCOLOGY 2001;61(4):299-305

Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: A comparison with serum expression
Lundin M, Nordling S, Lundin J, Alfthan H, Stenman Uh, Haglund C
INTERNATIONAL JOURNAL OF CANCER 2001;95(1):18-22

A prognostic value of syndecan-1 in gastric cancer
Wiksten Jp, Lundin J, Nordling S, Kokkola A, Haglund C
ANTICANCER RESEARCH 2000;20(6D):4905-7

Artificial neural networks applied to survival prediction in breast cancer
Lundin M, Lundin J, Burke Hb, Toikkanen S, Pylkkanen L, Joensuu H
ONCOLOGY 1999;57(4):281-6

Concentration of free hCG beta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx
Hedstrom J, Grenman R, Ramsay H, Finne P, Lundin J, Haglund C, et al
INTERNATIONAL JOURNAL OF CANCER 1999;84(5):525-8

Individualised survival prediction in breast cancer (BC) based on nation-wide follow-up data: The finprog study
Finnish Breast Canc Grp, Joensuu H, Lundin J, Lundin M, Holli K, Pylkkanen L, et al
EUROPEAN JOURNAL OF CANCER 1999;:S85-S85

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF
Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C
BRITISH JOURNAL OF CANCER 1999;80(11):1763-6

Severe acute pancreatitis - Prognostic factors in 270 consecutive patients
Halonen K, Puolakkainen P, Leppsniemi A, Lundin J, Kemppainen E, Hietaranta A, et al
GASTROENTEROLOGY 1999;116(4):A1130-A1130

Sialyl Tn is a frequently expressed antigen in colorectal cancer no correlation with patient prognosis.
Haglund Ch, Lundin M, Roberts Pj, Lundin J, Carpelan-holmstrsm M, Von Boguslawski K, et al
GASTROENTEROLOGY 1999;116(4):A417-A417

Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis
Lundin M, Nordling S, Roberts Pj, Lundin J, Carpelan-holmstrom M, Von Boguslawsky K, et al
ONCOLOGY 1999;57(1):70-6

Artificial neural networks in outcome prediction
Lundin J
ANNALES CHIRURGIAE ET GYNAECOLOGIAE 1998;87(2):128-30

Comparative genomic hybridization in childhood acute lymphoblastic leukemia
Larramendy Ml, Huhta T, Vettenranta K, El-rifai W, Lundin J, Pakkala S, et al
LEUKEMIA 1998;12(10):1638-44

Leucocyte nadir as a marker for chemotherapy efficacy in node positive breast cancer treated with adjuvant CMF
Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C
EUROPEAN JOURNAL OF CANCER 1998;:S8-S8

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer
Railo M, Lundin J, Haglund C, Von Smitten K, Von Boguslawsky K, Nordling S
Acta oncologica (Stockholm, Sweden) 1997;36(4):369-74

A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis
Victorzon M, Lundin J, Haglund C, Nordling S, Roberts Pj
International journal of cancer 1996;67(2):190-3

Expression of p53 protein as a prognostic factor in patients with gastric cancer
Victorzon M, Nordling S, Haglund C, Lundin J, Roberts Pj
EUROPEAN JOURNAL OF CANCER 1996;32A(2):215-20

Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer
Carpelanholmstrom M, Haglund C, Lundin J, Alfthan H, Stenman Uh, Roberts Pj
BRITISH JOURNAL OF CANCER 1996;74(6):925-9

Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer
Carpelanholmstrom M, Haglund C, Lundin J, Jarvinen H, Roberts P
EUROPEAN JOURNAL OF CANCER 1996;32A(7):1156-61

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer
Lundin J, Nordling S, Von Boguslawsky K, Roberts Pj, Haglund C
Oncology 1996;53(2):104-11

A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer
Victorzon M, Haglund C, Lundin J, Roberts Pj
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):379-84

Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9
Lundin J, Roberts Pj, Kuusela P, Haglund C
ANTICANCER RESEARCH 1995;15(5B):2181-6

Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer
Lundin J, Nordling S, Von Boguslawsky K, Roberts Pj, Haglund C
Anticancer research 1995;15(6B):2659-68

Visa alla publikationer